Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin
Cited by 29
Related Papers
Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway
|Oncotarget|2015|345
Methyltransferase-Like 3-Mediated m6A Methylation of Hsa_circ_0058493 Accelerates Hepatocellular Carcinoma Progression by Binding to YTH Domain-Containing Protein 1
|Frontiers in Cell and Developmental Biology|2021|59
The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice
|British Journal of Cancer|2008|52
Propofol Inhibits Proliferation, Migration, Invasion and Promotes Apoptosis Through Down-Regulating miR-374a in Hepatocarcinoma Cell Lines
|Cellular Physiology and Biochemistry|2018|35
AAZ2 induces mitochondrial-dependent apoptosis by targeting PDK1 in gastric cancer
|Journal of Zhejiang University SCIENCE B|2023|33